Table 3.

Univariate analysis of factors associated with weight loss attempts

Factor	Any weight loss attempt		MD guided weight loss attempt
	X2, n (%)	p value	X2, n (%)	p value
Agea	2.00	0.1578	1.00	0.3176
Race
Black (n=12)	4 (33.33%)	0.0557*	0 (0.00%)	0.0285*
White (n=88)	55 (62.50%)		17 (19.32%)
Distance
Milesa	1.09	0.2954	2.30	0.1294
Minutesa	1.33	0.2493	2.27	0.1320
Estmated Household Incomea,b	0.13	0.7156	0.01	0.9323
Baseline weighta	0.05	0.8149	0.49	0.4819
BMI in kg/m2a	0.00	0.9564	0.07	0.7946
Charlson Comorbidity Indexa	0.21	0.6474	0.03	0.8686
< 5 (n=76)	44 (57.89%)	0.6822	12 (15.79%)	0.5734
≥ 5 (n=24)	15 (62.5%)		5 (20.83%)
Pathology
Complex atypical hyperplasia (n=8)	7 (87.5%)	0.0662	2 (25.00%)	0.5300
Endometrial cancer (n=92)	52 (56.52%)		15 (16.30%)
Treatment
Surgical (n=93)	54 (58.06%)	0.4793	16 (17.20%)	0.8396
Nonsurgical (n=7)	5 (71.43%)		1 (1.08%)
Postop complications (no vs yes)
No (n=72)	43 (59.72%)	0.5500	15 (20.83%)	0.0556
Yes (n=21)	11 (52.38%)		1 (4.76%)
Surgical approach
Minimally invasive surgery (n=70)	39 (55.71%)	0.4198	11 (15.71%)	0.5152
Laparotomy (n=23)	15 (65.22%)		5 (21.74%)
Adjuvant therapy
Yes (n=28)	17 (60.71%)	0.7335	3 (10.71%)	0.2590
No (n=65)	37 (56.92%)		13 (20.00%
Treatment status at time of approach
Treatment ongoing (n=16)	10 (62.5%)	0.7552	2 (12.5%)	0.5892
Treatment completed (n=84)	49 (58.33%)		15 (17.86%)
Time from diagnosis when approacheda	0.45	0.5018	1.36	0.2427
< 1 year from diagnosis (n=45)	28 (62.22%)	0.5530	7 (15.56%)	0.7273
≥ 1 year from diagnosis (n=55)	31 (56.36%)		10 (18.18%)
Time from surgerya	0.04	0.8423	0.97	0.3237
< 1 year from surgery (n=43)	26 (60.47%)	0.6033	8 (18.60%)	0.5762
≥ 1 year from surgery (n=49)	27 (55.10%)		7 (14.29%)

^aAs a continuous variable tested with student t-tests.

^bHousehold income was estimated using published US census data regarding zip code median household incomes